125 related articles for article (PubMed ID: 37658767)
1. The therapeutic effect of oral desmopressin lyophilisate formulation in children with central diabetes insipidus.
Korkmaz HA; Coşkunol F; Barışık V; Ozkan B
J Pediatr Endocrinol Metab; 2023 Oct; 36(10):925-929. PubMed ID: 37658767
[TBL] [Abstract][Full Text] [Related]
2. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
3. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin lyophilisate for the treatment of central diabetes insipidus: first experience in very young infants.
De Waele K; Cools M; De Guchtenaere A; Van de Walle J; Raes A; Van Aken S; De Coen K; Vanhaesebrouck P; De Schepper J
Int J Endocrinol Metab; 2014 Oct; 12(4):e16120. PubMed ID: 25745483
[TBL] [Abstract][Full Text] [Related]
5. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.
De Bruyne P; De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
Eur J Pediatr; 2014 Feb; 173(2):223-8. PubMed ID: 23989967
[TBL] [Abstract][Full Text] [Related]
7. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
Ikeda H; Watanabe T; Isoyama K
Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
9. Transient Central Diabetes Insipidus Occurring After Vasopressin Infusion.
Cristiano EA; Harris A; Grdinovac K
AACE Clin Case Rep; 2022; 8(1):8-10. PubMed ID: 35097193
[TBL] [Abstract][Full Text] [Related]
10. Desmopressin oral lyophilisate in young children: new insights in pharmacokinetics and pharmacodynamics.
Dossche L; Michelet R; De Bruyne P; Van Herzeele C; Gasthuys E; Rittig S; Vermeulen A; Vande Walle J
Arch Dis Child; 2021 Jun; 106(6):597-602. PubMed ID: 32737054
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Hydrochlorothiazide and low renal solute feed in Neonatal Central Diabetes Insipidus with transition to Oral Desmopressin in early infancy.
Abraham MB; Rao S; Price G; Choong CS
Int J Pediatr Endocrinol; 2014; 2014(1):11. PubMed ID: 25002871
[TBL] [Abstract][Full Text] [Related]
12. Central diabetes insipidus is not a common and prognostically worse type of hypernatremia in neurointensive care.
Spatenkova V; Bradac O; Kazda A; Suchomel P
Neuro Endocrinol Lett; 2011; 32(6):879-84. PubMed ID: 22286785
[TBL] [Abstract][Full Text] [Related]
13. Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: a retrospective study of switching from intranasal desmopressin.
Murakami T; Hatoko T; Nambu T; Matsuda Y; Matsuo K; Yonemitsu S; Muro S; Oki S
Endocr J; 2014; 61(8):773-9. PubMed ID: 24849384
[TBL] [Abstract][Full Text] [Related]
14. Central diabetes insipidus: A rare complication of IVH in a very low birth weight preterm infant.
Thakore P; Dunbar AE; Lindsay EB
J Neonatal Perinatal Med; 2019; 12(1):103-107. PubMed ID: 30530977
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of two sublingual types of desmopressin in 6-year-old and more children with primary nocturnal enuresis. About an international randomized cross-over study].
Lottmann H
Prog Urol; 2009 Feb; 19(2):132-8. PubMed ID: 19168019
[TBL] [Abstract][Full Text] [Related]
16. Central Diabetes Insipidus in Infancy With or Without Hypothalamic Adipsic Hypernatremia Syndrome: Early Identification and Outcome.
Djermane A; Elmaleh M; Simon D; Poidvin A; Carel JC; Léger J
J Clin Endocrinol Metab; 2016 Feb; 101(2):635-43. PubMed ID: 26588450
[TBL] [Abstract][Full Text] [Related]
17. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.
Michelet R; Dossche L; Van Herzeele C; Van Bocxlaer J; Vermeulen A; Vande Walle J;
Eur J Clin Pharmacol; 2018 Mar; 74(3):297-305. PubMed ID: 29198064
[TBL] [Abstract][Full Text] [Related]
18. Central Diabetes Insipidus in a Patient With Lymphoma: A Case Report.
Koumpis E; Kyriazopoulou L; Tigas S; Kapsali E; Hatzimichael E
Cureus; 2023 Jul; 15(7):e41500. PubMed ID: 37551214
[TBL] [Abstract][Full Text] [Related]
19. Central Diabetes Insipidus in the Background of Lithium Use: Consider Central Causes Despite Nephrogenic as the Most Common.
Li JJ; Tan S; Kawashita T; Tagle CA; Farmand F
Am J Case Rep; 2023 Jan; 24():e939034. PubMed ID: 36683312
[TBL] [Abstract][Full Text] [Related]
20. Permanent central diabetes insipidus after traumatic brain injury. Case report and literature review.
Astafyeva LI; Sidneva YG; Badmaeva IN; Kalinin PL; Latyshev YA; Marshintsev AV; Valiullina SA
Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(5):112-118. PubMed ID: 36252201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]